A prospective, multicenter and cohort study on avoid recurrence in adenomyosis after conservative surgery using various drugs
Phase of Trial: Phase IV
Latest Information Update: 02 Aug 2018
At a glance
- Drugs Triptorelin (Primary)
- Indications Uterine cancer
- Focus Therapeutic Use
- 28 Jul 2018 Planned number of patients changed from 400 to 1128.
- 28 Jul 2018 Planned End Date changed from 30 Sep 2020 to 22 May 2021.
- 17 Oct 2017 New trial record